ArticleCureus2025
Kohler Disease With Concurrent Avascular Necrosis of the Medial Cuneiform: A Report of Two Cases.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Two patients, ages five and eight, presented to a pediatric orthopedic surgeon with dorsomedial midfoot pain. After further evaluation, each was diagnosed with idiopathic avascular necrosis of the navicular, also known as Kohler disease, with concurrent avascular necrosis of the ipsilateral medial cuneiform. Both patients were treated conservatively with rest, immobilization, limited weight-bearing, and reduced activity, and both saw resolution of symptoms and radiographic findings by the completion of follow-up. This report aims to reassure physicians that, even with uncommon and unexpected radiographic findings, Kohler disease can be managed conservatively and can result in full recovery and return to activity as soon as 12 weeks after initiating treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.